Clinical Trial Update: Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study comparing edaravone and ozagrel for acute ischemic stroke/cerebral infarction; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Edaravone (Edaravone)
• Ozagrel (ozagrel)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Cerebral Infarction | Phase 4 | Status: COMPLETED | Results posted: 2013-01-15